Literature DB >> 9406675

Passive smoking and coronary heart disease: a brief review.

T H Lam1, Y He.   

Abstract

1. Whether passive smoking or environmental tobacco smoke (ETS) can cause coronary heart disease (CHD) is controversial. We have undertaken a comprehensive review of the epidemiological studies regarding the relationship between ETS and CHD. 2. We searched for all original papers and reviews and calculated pooled odds ratio using the Mantel-Haenszel method. 3. Ten prospective studies, nine case-control studies and one cross-sectional study were found. Almost all studies showed positive associations between ETS and CHD and a few were statistically significant, with dose-response relationships being evident. Six review papers calculated pooled estimates of the relative risks, which ranged from 1.23 to 1.51. Other studies also showed that ETS could have other cardiovascular effects. 4. The association observed is likely to be real. The criteria for causation of time sequence, consistency, coherence and biological plausibility are satisfied. We conclude that ETS may cause CHD, particularly in women who have never smoked.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9406675     DOI: 10.1111/j.1440-1681.1997.tb02738.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  3 in total

1.  Short-term secondhand smoke exposure decreases heart rate variability and increases arrhythmia susceptibility in mice.

Authors:  Chao-Yin Chen; Drin Chow; Nipavan Chiamvimonvat; Kathryn A Glatter; Ning Li; Yuxia He; Kent E Pinkerton; Ann C Bonham
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-13       Impact factor: 4.733

2.  Epidemiologic studies of fatal and nonfatal cardiovascular disease and ETS exposure from spousal smoking.

Authors:  M Thun; J Henley; L Apicella
Journal:  Environ Health Perspect       Date:  1999-12       Impact factor: 9.031

3.  Identification of Risk Factors for Coronary Artery Disease in Asymptomatic Patients with Type 2 Diabetes Mellitus.

Authors:  Kazuhisa Takamura; Shinichiro Fujimoto; Tomoya Mita; Yuko Okano Kawaguchi; Mika Kurita; Satoshi Kadowaki; Yuki Kamo; Chihiro Aoshima; Yui Okada Nozaki; Daigo Takahashi; Ayako Kudo; Makoto Hiki; Nobuo Tomizawa; Fuki Ikeda; Hiroaki Satoh; Hirotaka Watada; Tohru Minamino
Journal:  J Clin Med       Date:  2022-02-24       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.